Page last updated: 2024-10-31
clorgyline and Cardiovascular Diseases
clorgyline has been researched along with Cardiovascular Diseases in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Clorgyline and pargyline were used as inhibitors of monoamine oxidase (MAO) A and B, respectively." | 1.27 | Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. ( Cox, LR; Grossman, SL; Ramos, K, 1988) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ramos, K | 1 |
Grossman, SL | 1 |
Cox, LR | 1 |
Other Studies
1 other study available for clorgyline and Cardiovascular Diseases
Article | Year |
---|---|
Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
Topics: Acrolein; Aldehydes; Allylamine; Amines; Animals; Benzylamine Oxidase; Cardiovascular Diseases; Cell | 1988 |